Growth Metrics

Envoy Medical (COCH) Change in Accured Expenses (2022 - 2026)

Envoy Medical's Change in Accured Expenses history spans 5 years, with the latest figure at $664000.0 for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 233.67% to $664000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.3 million, a 9.88% decrease, with the full-year FY2025 number at $839000.0, down 5.84% from a year prior.
  • Change in Accured Expenses hit $664000.0 in Q1 2026 for Envoy Medical, up from $623000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for COCH hit a ceiling of $1.3 million in Q3 2024 and a floor of -$982000.0 in Q2 2024.
  • Historically, Change in Accured Expenses has averaged $143117.6 across 5 years, with a median of $199000.0 in 2025.
  • The widest YoY moves for Change in Accured Expenses: up 361.4% in 2023, down 432.49% in 2023.
  • Tracing COCH's Change in Accured Expenses over 5 years: stood at $237000.0 in 2022, then plummeted by 432.49% to -$788000.0 in 2023, then skyrocketed by 217.64% to $927000.0 in 2024, then tumbled by 32.79% to $623000.0 in 2025, then grew by 6.58% to $664000.0 in 2026.
  • Business Quant data shows Change in Accured Expenses for COCH at $664000.0 in Q1 2026, $623000.0 in Q4 2025, and -$96000.0 in Q3 2025.